Abstract
INTRODUCTION
Pregnant adolescents and women commonly experience Major Depression (MD). The management of MD during pregnancy is complicated. Untreated maternal MD complicates pregnancy outcome and has both short and long-term ill effects on fetal development. Antidepressant exposure can be toxic to the fetus. Recently, the American College of Obstetricians and Gynecologists (ACOG) and the American Psychiatric Association (APA) have offered recommendations to manage MD during pregnancy. The report intends to help physicians and patients weigh the risks and benefits of various depression treatment alternatives during pregnancy (Grote, Bridge, Gavin, Melville, Iyengar, & Katon, 2010a). However, it remains to be determined if the recommendations have resulted in more standardized care for these patients.
Background
The mental health needs of pregnant adolescents and adult women are often overlooked (Misri, 2007) . A meta-analysis reported a high prevalence rate of antenatal depression (12.7 %) (Grote, Bridge, Gavin, Melville, Iyengar, & Katon, 2010b) . Similarly, systematic review of the literature suggests that 7.4 % of women experience major depressive episodes in their first trimester, 12.8% in second, and 12.0 % in the third trimester (Bennett, Einarson, Taddio, Koren, & Einarson, 2004) . A study of 40 pregnant adolescent females (mean age 15.6 years) found prevalence of MD in the moderate range of 72 % as measured by the Edinburg Post-Partum Depression Scale (EPDS )(Score ≥7) and 56% as measured by Beck Depression Inventory ( BDI) (score≥ 8) (Shanok & Miller, 2005) .Other epidemiological studies have found similar high rates of depression in pregnant teens ( Untreated MD in pregnancy has been associated with an increased risk of intrauterine growth restriction, increased rates of Cesarean Section, and increased rate of admissions of the infant to the neonatal intensive care unit (Misri, 2007 )(Grote, Bridge, Gavin, Melville, Iyengar, & Katon, 2010b) .
The American College of Obstetricians and Gynecologists (ACOG) finds insufficient evidence to support a firm recommendation for universal antepartum or post-partum screening for depression. However as depression screening has potential benefit, the ACOG suggests strong consideration for depression screening (American College of Obstetricians and Gynecologists Committee on Obstetric Practice, 2010). There are currently no recommendations for routine screenings for MD among pregnant adolescents (Misri, 2007) (Yonkers et al., 2009 ) .
The American Psychiatric Association (APA) has no guidelines for the treatment of MD during pregnancy. As a result the discrepancy in approaches of psychiatrists and OBGYNs is expected.
Serotonin reuptake inhibitors (SSRIs) are the first line of treatment for pregnant women experiencing severe mood disorders (Grote, (Gallagher, 2004) . Some studies on the herbal supplement indicate significant efficacy in treating MD while others report no significance of the supplement as an intervention. This is an exploratory study aimed to investigate the differences between academic OB/GYN physicians and academic Psychiatrists in the management of MD in pregnant adolescents and women. Specifically, we sought to assess the mode of interventions the academic OB/GYN and psychiatrists use to manage MD during adolescent and adult pregnancies. Additionally, we wanted to identify the rates of use for nonpharmacological interventions to treat depression during pregnancy in all ages by academic psychiatrists across the US. Understanding the treatment paradigms could lead to improved clinical outcomes for pregnant patients experiencing MD.
METHODS:
The Texas Tech University Health Science Center (TTUHSC) at the Permian Basin USA, departments of OB/GYN and Psychiatry created anonymous questionnaires. These questionnaires queried the accredited program directors of both OB/GYN and Psychiatry residency training programs across the United States about how they managed MD in adolescents ( age 13 years and above) and in adults . The 10 minute survey assessed individual and selfreport practices about managing MD during pregnancy. Areas assessed included modalities of intervention during mild, moderate, and severe MD, preference for counseling, preference for antidepressant intervention, comparison of use of screening tools between the two specialties, choice of antidepressant and assessment of use of non-pharmacological interventions such as ECT, light therapy and alternative medicines such as the Omega three fatty acids. The specialties when encountering an adolescent or adult pregnant female with varied severity of MD. Responses were limited to the individual training program directors. Individual phone calls to the mailed program directors were made to increase the response rates. A total of 51 academic OB/GYN programs and a total of 18 academic psychiatry training programs responded by completing and mailing back the questionnaires a response rate of 55% and 40 % respectively.
The Texas Tech University Health Science Center
Institutional Review Board approved all study procedures, and participants provided written informed release for anonymous and aggregate analysis and reporting of questionnaire data.
Analysis: Data for this study were analyzed using 2X2 Χ 2 techniques comparing group identification (OB/GYN and Psychiatrist) to response variables. All data were analyzed using SPSS version 15 software with an apriori significance level set at p<0.05.
RESULTS
Overall however, academic psychiatrists were more likely to prescribe antidepressant to pregnant adults and adolescents with clinical MDD than compared to academic OB/GYN physicians. When asked about the clinical practice for the use of antidepressants in adults and adolescents, 100% of psychiatrist approved of the practice compared to 80% of OB/GYN academic physicians .This difference was found to be statistically significant (Χ 2 = 4.2, P = 0.04).
For mild MD, more academic psychiatrists compared to academic OB/GYN physicians preferred counseling (72.2% versus 28.6%, Χ 2 = 12.296, P = 0.006). More OB/GYN physicians preferred to prescribe antidepressants for mild MD compared to psychiatrists. However, the difference was not statistically significant (11.1% versus 1%, Χ 2 = 3.55, P = 0.314). Such difference in opinion was not seen amongst the two specialties with moderate MD (Χ 2 = 0.00, P=1.0). When MD was assessed as severe, fewer OB/GYN physicians compared to psychiatrists were in favor of just 'continuing to evaluate' but this did not reach statistical significance (17.1% versus 22.2%, Χ 2 = 1.011, P = 0.799). For severe MD, more OB/GYN's compared to psychiatrists were in favor of referral for counseling but the difference was not statistically significant (72.2% versus 44.4%, Χ 2 = 5.19, P = 0.158). The proportion of clinicians in favor of intervening with antidepressant medications with severe clinical MD for both specialties were similar (73.3% for OB/GYN versus 76.5% for psychiatrist, Χ 2 = 1.786, P = 0.618). OB/GYN physicians were more likely to consult a psychiatrist or a psychologist when encountering severe depression during pregnancy (84.4%) than mild (0.03%) or moderate depression (37.8%).
Academic psychiatrists were more likely to initiate antidepressant medication based on the results of a depression inventory and clinical impression as opposed to just clinical impression alone. Hence, 38.9% of academic psychiatrist versus 32.6% of academic OB/GYN physicians relied on a combination of a depression inventory and clinical impression. The difference however was not statistically significant amongst the two specialties (Χ 2 = 1.476, P = 0.688). At the same time, 32.6% of academic OB/GYN respondents reported initiating antidepressant medication to pregnant depressed females on clinical impression only compared to 11.1% of academic psychiatrists. Again, the difference was not statistically significant (Χ 2 = 6.801, P = 0.079). More academic OB/GYN physicians (58.8%) preferred having a psychiatric consultation for depressed pregnant women and adolescents before initiating antidepressants. When asked if they would prescribe antidepressant to a depressed and suicidal pregnant female irrespective of age, 58.1% of academic OB/GYN physicians compared to 72.2% of academic psychiatrist responded positive (Χ 2= 5.1 4, P = 0.162). For both OB/GYN and psychiatrists, the choice of antidepressants were SSRIs (24.6%), followed by SNRIs (17.4%), tricyclic antidepressants (7.2%).
Overall, 52.2% of OB/GYN respondents reported using the formal screening tool for depression in pregnant females (women and adolescents). The most common reasons for use of such screening tools of depression during pregnancy were: current clinical history of MD (77.8%), previous history suggestive of MD (55.6%) and history of prior use of antidepressant medications (33.3%).
Significantly, only 14.5% of psychiatrists favored ECT treatment for severe MD during pregnancy. Only 4.3% and 1.4% of surveyed academic psychiatrists approved of ECT treatment for mild and moderate MD, respectively.
For Light Therapy, only 1.4% of academic psychiatrists approved treatment of MD during pregnancy irrespective of its severity.
For Omega 3 fatty acids, 4.3% of academic psychiatrist responding to the survey approved of treatment of MD during pregnancy irrespective of severity of depression.
DISCUSSIONS
Academic OB/GYN physicians compared to academic psychiatrists were more likely to use medications in pregnant mother (adults and adolescents) with 'mild' MD. With increasing severity of MD, the psychiatrists are more likely to intervene with psychotherapy first and use medications only if depression continues to deteriorate. With moderate to severe maternal depression, physicians from both specialties were equally likely to intervene rather than display watchful expectancy. When suicidal thoughts are present, the psychiatrists were more likely to start antidepressants. This disparity in approach to treat mild depression with supportive care during pregnancy may reflect the OB/GYN physician's lack of comfort or time to engage in psychotherapy.
Majority of psychiatrists and OB/GYN elected to intervene with mild to moderate maternal MD. This is encouraging as untreated maternal depression is linked to increasing adverse pregnancy outcomes. These include premature birth, low birth weight infants, fetal growth check, and postnatal complications (Yonkers et al., 2009 ) . The maternal MD during pregnancy has been linked to increased life stresses, decrease social support, more maternal weight gain, smoking and substance abuse (Grote, Bridge, Gavin, Melville, Iyengar, & Katon, 2010a). Infants born to untreated depressed mothers cry more and can be difficult to console (Field The Expert Consensus Guidelines Series regarding treating first or recurrent episode for mild MD during first trimester of pregnancy recommends using psychotherapy alone as first line of intervention. In contrast, for a severe MD, the treatment of choice is combining medication and psychotherapy, whether first episode or recurrent (Altshuler et al., 2001 ). Psychotherapy alone was a feasible second-line option only for a first lifetime episode. In a patient who has a history of severe, recurrent episodes of depression but who is only showing early signs of a relapse, the experts had no first-line consensus, but the majority recommends intervening with psychotherapy alone in the hopes of preventing a full syndrome from developing. (Altshuler et al., 2001 ). For treatment of first episode of mild MD during second or third trimester, the experts recommend using psychotherapy alone. In contrast, for a first episode of severe depression, the treatment of choice is combining medication and psychotherapy whether the episode began during the latter part of pregnancy or earlier, with medication alone an option to consider (Altshuler et al., 2001 ).
Majority of the OB/GYN physicians indicated using a formal screening tool for depression. Only one third psychiatrists used depression screening tool. Psychiatrists seem to rely more on clinical impressions to manage MD. Surveys have found that only 10-15 % of the community psychiatrists use depression screening tools (Rush, 2009 ). Depression screening tools may not be sensitive to tease out many symptoms of depression from pregnancy related events (trouble with sleep, tiredness, emotional labiality, etc.). However; such screening tools can be time saving and effective in quantifying response to treatment.
The joint report from the APA and the ACOG on the management of MD in pregnancy finds that the routine use of self-report screening instrument does not replace or supplant clinical diagnosis but can determine which women require further assessment (Altshuler et al., 2001 ). Edinburgh Post-Partum Depression Scale is the most commonly used screening questionnaire for depression in pregnancy with a cut off score of There was early enthusiasm for omega-3 fatty acids, although most randomized clinical trials to date have failed to show that the active treatment differs from placebo. (Freeman et al., 2006) , (Rees, Austin, & Parker, 2005) . However meta-analysis for the role of omega-3 fatty acids for maternal MD has been found to be less consistent and further definitive studies are needed (Hosli, Zanetti-Daellenbach, Holzgreve, & Lapaire, 2007) . A recent systematic review of maternal omega 3 fatty acid supplementation and risk for perinatal maternal depression found that of ten studies found eligible for study only two showed a positive association between -3 fatty acids and reduced incidence of maternal perinatal depression (Wojcicki & Heyman, 2011 ).
There are several limitations to our study including the small numbers of participant, lack of evidence of reliability or validity of the questionnaires and lack of uniformity in assessing severity of depression. The stage of pregnancy was not taken into consideration while assessing mood symptoms. Approach to clinical depression during pregnancy can be influenced by the stage of pregnancy as most clinicians are more conservative towards psychopharmacological approach during early stages of pregnancy. There is also lack of evidence that recommendations and opinions as expressed by the respondents may not represent actual clinical practice. The questionnaire designed was not standardized for its validity or reliability. The response rates from the two clinical specialties were disproportionate and hence the may not be reflective of true trends of intervention during adolescent or adult pregnancies compared to national norms.
To the best of our knowledge, this is a unique study with no precedents in the published literature. Hence there is no available data to compare.
In our opinion, this preliminary exploratory study has tried for the first time the disparities between the practice guidelines and actual practice of intervention of maternal depression during pregnancy by two important specialties of medicine. It lays groundwork for further evaluations and for more definitive studies in future. An important aspect would be comparison of the intervention practices of these important specialties between the academic and nonacademic clinicians. 
